China SFDA To Step Up Actions Against Counterfeit Of 'Essential Drugs'
This article was originally published in PharmAsia News
Executive Summary
China's State FDA plans to increase its operations with law-enforcement agencies to stop the market of counterfeit drugs, beginning with medicines on its list of those deemed essential.